依诺沙星倍半水合物 T0717

Product Introduction
Bioactivity


英文名: Enoxacin hydrate

描述: Enoxacin hydrate (AT-2266 hydrate) 是氟喹诺酮，可干扰DNA 复制，抑制细菌 DNA 促旋酶 (IC50=126 µg/ml) 和拓扑异构酶 IV (IC50=26.5 µg/ml)。它是特异性癌症生长抑制剂，抑制革兰氏阳性和阴性细菌。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : < 1mg/ml (insoluble）


关键字: mRNA | AT-2266 Hydrate | DNA/RNA Synthesis | siRNA | gram-positive | AT2266 | Bacterial | CI919 | topoisomerase | CI-919 Hydrate | Inhibitor | gyrase | CI 919 Hydrate | AT 2266 Hydrate | TRBP | Antibiotic | AT2266 Hydrate | Enoxacin | miRNA | Enoxacin hydrate | CI919 Hydrate | AT 2266 | MicroRNA | gram-negative | inhibit | DNA | CI-919 | TAR-RNA | CI 919 | Enoxacin Hydrate | AT-2266

相关产品: Levofloxacin hydrate | Novobiocin | Zoliflodacin | Norfloxacin | Trovafloxacin | Sparfloxacin | Novobiocin Sodium | BRD7116 | Gemifloxacin mesylate | Fleroxacin

相关库: Drug Repurposing Compound Library | Approved Drug Library | Cell Cycle Compound Library | FDA-Approved & Pharmacopeia Drug Library | Anti-Cancer Drug Library | Inhibitor Library | Epigenetics Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Approved Drug Library | Anti-Bacterial Compound Library

依诺沙星倍半水合物 T0717信息由TargetMol中国为您提供，如您想了解更多关于依诺沙星倍半水合物 T0717报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途